These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18617640)

  • 1. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption.
    Gordin FM; Roediger MP; Girard PM; Lundgren JD; Miro JM; Palfreeman A; Rodriguez-Barradas MC; Wolff MJ; Easterbrook PJ; Clezy K; Slater LN
    Am J Respir Crit Care Med; 2008 Sep; 178(6):630-6. PubMed ID: 18617640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007.
    Bénard A; Mercié P; Alioum A; Bonnet F; Lazaro E; Dupon M; Neau D; Dabis F; Chêne G;
    PLoS One; 2010 Jan; 5(1):e8896. PubMed ID: 20126646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS.
    Burns DN; Hillman D; Neaton JD; Sherer R; Mitchell T; Capps L; Vallier WG; Thurnherr MD; Gordin FM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(4):374-83. PubMed ID: 8948377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study.
    Kohli R; Lo Y; Homel P; Flanigan TP; Gardner LI; Howard AA; Rompalo AM; Moskaleva G; Schuman P; Schoenbaum EE;
    Clin Infect Dis; 2006 Jul; 43(1):90-8. PubMed ID: 16758423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.
    Lifson AR; Neuhaus J; Arribas JR; van den Berg-Wolf M; Labriola AM; Read TR;
    Am J Public Health; 2010 Oct; 100(10):1896-903. PubMed ID: 20724677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans.
    Crothers K; Griffith TA; McGinnis KA; Rodriguez-Barradas MC; Leaf DA; Weissman S; Gibert CL; Butt AA; Justice AC
    J Gen Intern Med; 2005 Dec; 20(12):1142-5. PubMed ID: 16423106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking in the HIV-infected population.
    Rahmanian S; Wewers ME; Koletar S; Reynolds N; Ferketich A; Diaz P
    Proc Am Thorac Soc; 2011 Jun; 8(3):313-9. PubMed ID: 21653534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).
    Pett SL; Carey C; Lin E; Wentworth D; Lazovski J; Miró JM; Gordin F; Angus B; Rodriguez-Barradas M; Rubio R; Tambussi G; Cooper DA; Emery S;
    HIV Med; 2011 Apr; 12(4):219-27. PubMed ID: 20812949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, timing, and determinants of bacterial pneumonia among HIV-infected patients: data from the ICONA Foundation Cohort.
    Mussini C; Galli L; Lepri AC; De Luca A; Antinori A; Libertone R; Angarano G; Bonfanti P; Castagna A; DʼArminio Monforte A;
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):339-45. PubMed ID: 23591636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy.
    Shuter J; Bernstein SL
    Nicotine Tob Res; 2008 Apr; 10(4):731-6. PubMed ID: 18418794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 and bacterial pneumonia in the era of antiretroviral therapy.
    Segal LN; Methé BA; Nolan A; Hoshino Y; Rom WN; Dawson R; Bateman E; Weiden MD
    Proc Am Thorac Soc; 2011 Jun; 8(3):282-7. PubMed ID: 21653529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.
    Bjerk SM; Baker JV; Emery S; Neuhaus J; Angus B; Gordin FM; Pett SL; Stephan C; Kunisaki KM;
    PLoS One; 2013; 8(2):e56249. PubMed ID: 23457535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort Study.
    Balakrishna S; Wolfensberger A; Kachalov V; Roth JA; Kusejko K; Scherrer AU; Furrer H; Hauser C; Calmy A; Cavassini M; Schmid P; Bernasconi E; Battegay M; Günthard HF; Kouyos RD;
    J Infect Dis; 2022 May; 225(9):1592-1600. PubMed ID: 34792153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease.
    Miguez-Burbano MJ; Ashkin D; Rodriguez A; Duncan R; Pitchenik A; Quintero N; Flores M; Shor-Posner G
    Int J Infect Dis; 2005 Jul; 9(4):208-17. PubMed ID: 15916913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.
    ; El-Sadr WM; Grund B; Neuhaus J; Babiker A; Cohen CJ; Darbyshire J; Emery S; Lundgren JD; Phillips A; Neaton JD
    Ann Intern Med; 2008 Sep; 149(5):289-99. PubMed ID: 18765698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology of pulmonary complications of human immunodeficiency virus-1-infected patients in Taiwan in the era of combination antiretroviral therapy: a prospective observational study.
    Lee KY; Ho CC; Ji DD; Lee CM; Tsai MS; Cheng AC; Chen PY; Tsai SY; Tseng YT; Sun HY; Lee YC; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2013 Dec; 46(6):433-40. PubMed ID: 23026388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries.
    Jaquet A; Ekouevi DK; Aboubakrine M; Bashi J; Messou E; Maiga M; Traore HA; Zannou M; Guehi C; Ba-Gomis FO; Minga A; Allou G; Eholie SP; Dabis F; Bissagnene E; Sasco AJ
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1433-9. PubMed ID: 19861019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief Report: Cofactors of Mortality Among Hospitalized HIV-Infected Children Initiating Antiretroviral Therapy in Kenya.
    Njuguna IN; Cranmer LM; Wagner AD; LaCourse SM; Mugo C; Benki-Nugent S; Richardson BA; Stern J; Maleche-Obimbo E; Wamalwa DC; John-Stewart G
    J Acquir Immune Defic Syndr; 2019 Jun; 81(2):138-144. PubMed ID: 31095004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
    O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
    Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.